These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8437528

  • 1. [Molsidomine in chronic heart failure with liver congestion--oral or intravenous therapy?].
    Grosse-Heitmeyer W, Huber T, Ostrowski J.
    Med Klin (Munich); 1993 Jan 15; 88(1):21-5. PubMed ID: 8437528
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A, Escudier B, Hannachi N, Kolski H, Witchitz S, Acar J.
    Arch Mal Coeur Vaiss; 1984 Jan 15; 77(1):92-9. PubMed ID: 6422898
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P, Eha J, Sundberg S, Antila S, Heinpalu M, Loogna I, Planken U, Rantanen S, Lehtonen L.
    Int J Clin Pharmacol Ther; 2003 Aug 15; 41(8):365-73. PubMed ID: 12940594
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN.
    J Cardiovasc Pharmacol; 2009 Feb 15; 53(2):157-61. PubMed ID: 19188832
    [Abstract] [Full Text] [Related]

  • 12. Liver function and pharmacokinetics of molsidomine and its metabolite 3-morpholinosydnonimine in healthy volunteers.
    Wildgrube HJ, Ostrowski J, Chamberlain J, Gärtner W, Stockhausen H.
    Arzneimittelforschung; 1986 Jul 15; 36(7):1129-33. PubMed ID: 3768083
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R.
    J Heart Lung Transplant; 1997 May 15; 16(5):556-62. PubMed ID: 9171275
    [Abstract] [Full Text] [Related]

  • 18. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R, Grewe R.
    Med Klin (Munich); 1994 Jul 15; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.